Increased uptake of biosimilars could save the NHS up to £300m a year

NHS England has set out plans to accelerate and widen the NHS ’s use of biosimilars to cut up to £300m a year from the drug bill by 2021.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research